A recombinant vaccine based on i-Particles is protective against H1N1 influenza infection
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection Context Cilian AG (Germany), affiliated as.
Read More 
FASTCURE: a consortium of experts to respond to the epidemic COVID-19 coronavirus outbreak
FASTCURE is a consortium of experts for screening, identification and formulation of chemical compounds to combat SARS-CoV-2. Drug repurposing can.
Read More 
Antibiotic incorporation in jet-sprayed nanofibrillar biodegradable scaffolds for wound healing
Abstract In view of preparing antibiotic-loaded structures that can be used as dressing to prevent or contain wound infections, this.
Read More 
11ème édition des Journées Collaboratives
Adjuvatis is going to the Partnering Days organized by the Bio Cluster Lyonbiopole to participate in brainstorming sessions and to.
Read More 
Funding awarded for an Innovative Training Network, DRIVE!
Adjuvatis is hiring a PhD Student for 3 years starting at May 2018 The European Innovative Training Network DRIVE (Driving.
Read More 
Groupement de Recherche Cosm’actifs – GDR 3711
Adjuvatis is invited to present the results of researches conducted on drug delivery in the skin by using the i-Particles.
Read More